Tryp Therapeutics Inc. Joins the CSE for a Virtual Market Open

The CSE excitedly welcomed Tryp Therapeutics Inc. (CSE:TRYP) for a virtual Market Open on December 14th, 2020. 

Tryp Therapeutics is a pharmaceutical company focused on developing transformative medicine for orphan diseases and other diseases with high unmet medical needs. Currently, Tryp Therapeutics is working on advancing two different medical treatments. The first is designed to address neurological disorders, and the second is for soft-tissue sarcoma, a rare type of cancer tumour.

To open the day’s trading session, Tryp Therapeutics CEO James Kuo, MD, and his enthusiastic team joined the CSE for the momentous virtual event. 

For more details about the CSE, including information on other Market Opens, please visit the CSE website or follow us on social media.